Extracorporeal Membrane Oxygenation in Pregnant and Postpartum Women With H1N1-Related Acute Respiratory Distress Syndrome

Antonio Saad, Mahbubur Rahman, Dirk M. Maybauer, John F. Fraser, Maged Costantine, Luis Pacheco, Marc O. Maybauer

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

OBJECTIVE: To assess available evidence regarding the use of extracorporeal membrane oxygenation (ECMO) in pregnant and postpartum women with acute respiratory distress syndrome (ARDS) secondary to H1N1 infection. DATA SOURCES: Databases from MEDLINE (U.S. National Library of Medicine, 1946 to April 1, 2015), the Cochrane Library Controlled Trials Register, ClinicalTrials.gov, and Web of Science were queried for studies on ECMO in pregnant or postpartum patients with ARDS. Search terms included: "ARDS," "ECMO," "pregnant," and "postpartum." TABULATION, INTEGRATION, AND RESULTS: All relevant references in any language were reviewed. Literature for inclusion and methodologic quality were reviewed based on the meta-analyses and systematic reviews of observational studies (Meta-analysis Of Observational Studies in Epidemiology) guidelines. Of 266 citations, five retrospective studies (39 patients) fulfilled our inclusion criteria. No randomized controlled trials were found. The pooled estimate of the survival rate among pregnant and postpartum patients who received ECMO for ARDS secondary to H1N1 was 74.6% (95% confidence interval [CI] 60.7-88.6%). Neonatal outcomes were reported in two studies and the rate of live birth was 70% (95% CI 43.7-95.2). Heterogeneity was not significant among studies (I 2 ranged from 0% to 21%; P>.25). CONCLUSION: The role of ECMO in pregnant and postpartum women with ARDS from H1N1 remains unclear and the benefits suggested from our review should be interpreted with caution.

Original languageEnglish (US)
Pages (from-to)241-247
Number of pages7
JournalObstetrics and Gynecology
Volume127
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Adult Respiratory Distress Syndrome
Postpartum Period
Pregnant Women
Observational Studies
Meta-Analysis
Confidence Intervals
National Library of Medicine (U.S.)
Live Birth
MEDLINE
Libraries
Epidemiology
Language
Survival Rate
Randomized Controlled Trials
Retrospective Studies
Databases
Guidelines
Infection

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Extracorporeal Membrane Oxygenation in Pregnant and Postpartum Women With H1N1-Related Acute Respiratory Distress Syndrome. / Saad, Antonio; Rahman, Mahbubur; Maybauer, Dirk M.; Fraser, John F.; Costantine, Maged; Pacheco, Luis; Maybauer, Marc O.

In: Obstetrics and Gynecology, Vol. 127, No. 2, 01.02.2016, p. 241-247.

Research output: Contribution to journalArticle

Saad, Antonio ; Rahman, Mahbubur ; Maybauer, Dirk M. ; Fraser, John F. ; Costantine, Maged ; Pacheco, Luis ; Maybauer, Marc O. / Extracorporeal Membrane Oxygenation in Pregnant and Postpartum Women With H1N1-Related Acute Respiratory Distress Syndrome. In: Obstetrics and Gynecology. 2016 ; Vol. 127, No. 2. pp. 241-247.
@article{64e1558f25fc49859edcfb32ef66dc35,
title = "Extracorporeal Membrane Oxygenation in Pregnant and Postpartum Women With H1N1-Related Acute Respiratory Distress Syndrome",
abstract = "OBJECTIVE: To assess available evidence regarding the use of extracorporeal membrane oxygenation (ECMO) in pregnant and postpartum women with acute respiratory distress syndrome (ARDS) secondary to H1N1 infection. DATA SOURCES: Databases from MEDLINE (U.S. National Library of Medicine, 1946 to April 1, 2015), the Cochrane Library Controlled Trials Register, ClinicalTrials.gov, and Web of Science were queried for studies on ECMO in pregnant or postpartum patients with ARDS. Search terms included: {"}ARDS,{"} {"}ECMO,{"} {"}pregnant,{"} and {"}postpartum.{"} TABULATION, INTEGRATION, AND RESULTS: All relevant references in any language were reviewed. Literature for inclusion and methodologic quality were reviewed based on the meta-analyses and systematic reviews of observational studies (Meta-analysis Of Observational Studies in Epidemiology) guidelines. Of 266 citations, five retrospective studies (39 patients) fulfilled our inclusion criteria. No randomized controlled trials were found. The pooled estimate of the survival rate among pregnant and postpartum patients who received ECMO for ARDS secondary to H1N1 was 74.6{\%} (95{\%} confidence interval [CI] 60.7-88.6{\%}). Neonatal outcomes were reported in two studies and the rate of live birth was 70{\%} (95{\%} CI 43.7-95.2). Heterogeneity was not significant among studies (I 2 ranged from 0{\%} to 21{\%}; P>.25). CONCLUSION: The role of ECMO in pregnant and postpartum women with ARDS from H1N1 remains unclear and the benefits suggested from our review should be interpreted with caution.",
author = "Antonio Saad and Mahbubur Rahman and Maybauer, {Dirk M.} and Fraser, {John F.} and Maged Costantine and Luis Pacheco and Maybauer, {Marc O.}",
year = "2016",
month = "2",
day = "1",
doi = "10.1097/AOG.0000000000001236",
language = "English (US)",
volume = "127",
pages = "241--247",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Extracorporeal Membrane Oxygenation in Pregnant and Postpartum Women With H1N1-Related Acute Respiratory Distress Syndrome

AU - Saad, Antonio

AU - Rahman, Mahbubur

AU - Maybauer, Dirk M.

AU - Fraser, John F.

AU - Costantine, Maged

AU - Pacheco, Luis

AU - Maybauer, Marc O.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - OBJECTIVE: To assess available evidence regarding the use of extracorporeal membrane oxygenation (ECMO) in pregnant and postpartum women with acute respiratory distress syndrome (ARDS) secondary to H1N1 infection. DATA SOURCES: Databases from MEDLINE (U.S. National Library of Medicine, 1946 to April 1, 2015), the Cochrane Library Controlled Trials Register, ClinicalTrials.gov, and Web of Science were queried for studies on ECMO in pregnant or postpartum patients with ARDS. Search terms included: "ARDS," "ECMO," "pregnant," and "postpartum." TABULATION, INTEGRATION, AND RESULTS: All relevant references in any language were reviewed. Literature for inclusion and methodologic quality were reviewed based on the meta-analyses and systematic reviews of observational studies (Meta-analysis Of Observational Studies in Epidemiology) guidelines. Of 266 citations, five retrospective studies (39 patients) fulfilled our inclusion criteria. No randomized controlled trials were found. The pooled estimate of the survival rate among pregnant and postpartum patients who received ECMO for ARDS secondary to H1N1 was 74.6% (95% confidence interval [CI] 60.7-88.6%). Neonatal outcomes were reported in two studies and the rate of live birth was 70% (95% CI 43.7-95.2). Heterogeneity was not significant among studies (I 2 ranged from 0% to 21%; P>.25). CONCLUSION: The role of ECMO in pregnant and postpartum women with ARDS from H1N1 remains unclear and the benefits suggested from our review should be interpreted with caution.

AB - OBJECTIVE: To assess available evidence regarding the use of extracorporeal membrane oxygenation (ECMO) in pregnant and postpartum women with acute respiratory distress syndrome (ARDS) secondary to H1N1 infection. DATA SOURCES: Databases from MEDLINE (U.S. National Library of Medicine, 1946 to April 1, 2015), the Cochrane Library Controlled Trials Register, ClinicalTrials.gov, and Web of Science were queried for studies on ECMO in pregnant or postpartum patients with ARDS. Search terms included: "ARDS," "ECMO," "pregnant," and "postpartum." TABULATION, INTEGRATION, AND RESULTS: All relevant references in any language were reviewed. Literature for inclusion and methodologic quality were reviewed based on the meta-analyses and systematic reviews of observational studies (Meta-analysis Of Observational Studies in Epidemiology) guidelines. Of 266 citations, five retrospective studies (39 patients) fulfilled our inclusion criteria. No randomized controlled trials were found. The pooled estimate of the survival rate among pregnant and postpartum patients who received ECMO for ARDS secondary to H1N1 was 74.6% (95% confidence interval [CI] 60.7-88.6%). Neonatal outcomes were reported in two studies and the rate of live birth was 70% (95% CI 43.7-95.2). Heterogeneity was not significant among studies (I 2 ranged from 0% to 21%; P>.25). CONCLUSION: The role of ECMO in pregnant and postpartum women with ARDS from H1N1 remains unclear and the benefits suggested from our review should be interpreted with caution.

UR - http://www.scopus.com/inward/record.url?scp=84955440896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955440896&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000001236

DO - 10.1097/AOG.0000000000001236

M3 - Article

C2 - 26942349

AN - SCOPUS:84955440896

VL - 127

SP - 241

EP - 247

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 2

ER -